Kurma Partners

Paris-based healthcare and biotech venture capital firm, part of the Eurazeo group, that creates and funds companies from academic research and invests from seed through late-stage growth in therapeutics, diagnostics and healthtech.

Type: VC firm
Location: Paris, France
Stages: Pre-seed, Seed, Series A, Series B, Growth
Sectors: Healthtech and life sciences, Biotech, Diagnostics, Healthtech
Fund size / AUM: EUR 890 million under management; Kurma Biofund IV EUR 215M final close 2026; Kurma Growth Opportunities EUR 167M (2024); Kurma Diagnostics II EUR 83M (own site)
Website: www.kurmapartners.com/en

Contacts on file

For Kurma Partners, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.

Get Europe Complete, $99 Free sample

One-time payment. No subscription. No account.

Notable investments

Amolyt PharmaAdcytherixArkhnBioSerenityArgobio Studio

Sources

Last checked 7 Nov 2026. Is something wrong? Tell us.

Appears in 37 lists

Medtech investors in Europe (45)Series B medtech investors (57)Healthtech investors in Paris (60)Series B biotech investors (73)Venture capital firms in France (81)Biotech investors in Europe (89)Growth-stage medtech investors (107)Growth-stage biotech investors (109)Startup investors in Paris (114)Series B investors in Europe (117)Series A medtech investors (125)Pre-seed medtech investors (129)Pre-seed biotech investors (148)Series A biotech investors (153)Series B healthtech investors (160)Startup investors in France (189)Pre-seed investors in Europe (260)Growth-stage investors in Europe (276)Seed medtech investors (278)Healthtech investors in Europe (291)Seed biotech investors (300)Growth-stage healthtech investors (316)Series A investors in Europe (329)Series B investors (339)Series A healthtech investors (401)Pre-seed healthtech investors (408)Venture capital firms in Europe (412)Medtech investors (457)Biotech investors (484)Seed investors in Europe (543)Growth-stage investors (705)Startup investors in Europe (725)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Healthtech investors (1,207)Seed investors (1,892)